Vext Science(VEXTF)
$0.160.00 (0.00%)
VEXTF
Vext Science financials statements
$0.16
At close:0.00 (0.00%)
Vext Science (VEXTF) Ratios
35 Followers
Vext Science Ratios
VEXTF's free cash flow for Q3 2026 was $-4.50M. For the 2026 fiscal year, VEXTF's free cash flow was decreased by $-6.88M and operating cash flow was $2.38M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.59 | 1.48 | 2.95 | 4.06 | 3.20 |
| Quick Ratio | 0.33 | 0.73 | 2.08 | 3.00 | 3.18 |
| Cash Ratio | 0.18 | 0.26 | 0.62 | 0.46 | 0.66 |
| Solvency Ratio | -0.03 | -0.12 | 0.26 | 0.35 | 0.34 |
| Operating Cash Flow Ratio | 0.42 | 0.18 | 0.32 | 0.46 | 1.20 |
| Short-Term Operating Cash Flow Coverage | 1.59 | 0.71 | 0.76 | 1.02 | 1.82 |
| Net Current Asset Value | $ -48.28M | $ -34.84M | $ -13.29M | $ 4.08M | $ 6.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.29 | 0.26 | 0.32 | 0.17 |
| Debt-to-Equity Ratio | 0.63 | 0.52 | 0.41 | 0.53 | 0.24 |
| Debt-to-Capital Ratio | 0.39 | 0.34 | 0.29 | 0.35 | 0.19 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.29 | 0.24 | 0.30 | 0.11 |
| Financial Leverage Ratio | 2.18 | 1.81 | 1.57 | 1.68 | 1.41 |
| Debt Service Coverage Ratio | 0.32 | -0.39 | 1.85 | 2.45 | 1.27 |
| Interest Coverage Ratio | -1.86 | -2.85 | -0.47 | 4.35 | 4.25 |
| Debt to Market Cap | 0.67 | 1.23 | 1.00 | 1.52 | 0.20 |
| Interest Debt Per Share | 0.16 | 0.18 | 0.26 | 0.29 | 0.12 |
| Net Debt to EBITDA | 4.39 | -17.27 | 1.78 | 2.14 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 4.44% | 24.94% | 34.58% | 65.23% | 50.17% |
| EBIT Margin | -17.89% | -47.77% | 20.61% | 25.00% | 25.60% |
| EBITDA Margin | 13.02% | -5.61% | 48.17% | 42.45% | 34.36% |
| Operating Profit Margin | -17.89% | -31.06% | -5.18% | 25.22% | 25.47% |
| Pretax Profit Margin | -29.62% | -58.68% | 9.66% | 18.91% | 18.31% |
| Net Profit Margin | -35.03% | -62.32% | 12.63% | 30.84% | 13.39% |
| Continuous Operations Profit Margin | -35.03% | -62.32% | 12.63% | 30.84% | 13.39% |
| Net Income Per EBT | 118.27% | 106.22% | 130.80% | 163.03% | 73.12% |
| EBT Per EBIT | 165.53% | 188.93% | -186.60% | 75.01% | 71.90% |
| Return on Assets (ROA) | -15.22% | -16.38% | 2.94% | 9.06% | 5.96% |
| Return on Equity (ROE) | -33.12% | -29.62% | 4.63% | 15.18% | 8.40% |
| Return on Capital Employed (ROCE) | -10.18% | -9.39% | -1.33% | 8.30% | 12.82% |
| Return on Invested Capital (ROIC) | -9.33% | -8.97% | -1.27% | 7.87% | 8.63% |
| Return on Tangible Assets | -33.15% | -33.20% | 5.14% | 11.84% | 6.52% |
| Earnings Yield | -39.82% | -77.34% | 12.23% | 44.42% | 7.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 20.35 | 19.84 | 4.13 | 1.59 | 1.59 |
| Payables Turnover | 9.50 | 7.23 | 11.15 | 7.25 | 13.55 |
| Inventory Turnover | 6.70 | 2.03 | 1.86 | 0.89 | 86.37 |
| Fixed Asset Turnover | 1.36 | 0.91 | 0.85 | 0.97 | 1.28 |
| Asset Turnover | 0.43 | 0.26 | 0.23 | 0.29 | 0.44 |
| Working Capital Turnover Ratio | -33.15 | 2.01 | 1.04 | 1.16 | 2.04 |
| Cash Conversion Cycle | 34.00 | 147.81 | 251.73 | 587.24 | 207.47 |
| Days of Sales Outstanding | 17.94 | 18.40 | 88.29 | 229.61 | 230.19 |
| Days of Inventory Outstanding | 54.47 | 179.89 | 196.17 | 408.00 | 4.23 |
| Days of Payables Outstanding | 38.41 | 50.48 | 32.73 | 50.37 | 26.95 |
| Operating Cycle | 72.41 | 198.28 | 284.46 | 637.61 | 234.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.01 | 0.03 | 0.04 | 0.09 |
| Free Cash Flow Per Share | 0.03 | 0.01 | 0.01 | -0.02 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | 3.28 | 2.24 | 1.62 | 0.67 | 0.62 |
| Capital Expenditure Coverage Ratio | 3.28 | 2.24 | 1.62 | 0.67 | 0.62 |
| Operating Cash Flow Coverage Ratio | 0.34 | 0.08 | 0.11 | 0.16 | 0.83 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.09 | 0.13 | 0.17 | 0.31 |
| Free Cash Flow Yield | 18.03% | 6.29% | 4.69% | -11.95% | -10.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.55 | -1.30 | 8.18 | 2.25 | 13.87 |
| Price-to-Sales (P/S) Ratio | 0.88 | 0.81 | 1.03 | 0.69 | 1.86 |
| Price-to-Book (P/B) Ratio | 0.83 | 0.38 | 0.38 | 0.34 | 1.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.55 | 15.91 | 21.31 | -8.37 | -9.74 |
| Price-to-Operating Cash Flow Ratio | 3.86 | 8.82 | 8.13 | 4.15 | 5.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | 0.00 | -0.13 | 0.02 | 0.28 |
| Enterprise Value Multiple | 11.15 | -31.62 | 3.93 | 3.78 | 6.00 |
| Enterprise Value | 75.87M | 63.90M | 65.84M | 56.80M | 76.81M |
| EV to EBITDA | 11.15 | -31.62 | 3.93 | 3.78 | 6.00 |
| EV to Sales | 1.45 | 1.78 | 1.89 | 1.60 | 2.06 |
| EV to Free Cash Flow | 9.16 | 35.05 | 39.01 | -19.34 | -10.81 |
| EV to Operating Cash Flow | 6.37 | 19.43 | 14.88 | 9.59 | 6.58 |
| Tangible Book Value Per Share | -0.04 | 0.03 | 0.19 | 0.31 | 0.38 |
| Shareholders’ Equity Per Share | 0.22 | 0.31 | 0.58 | 0.52 | 0.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.18 | -0.06 | -0.31 | -0.63 | 0.27 |
| Revenue Per Share | 0.21 | 0.15 | 0.21 | 0.26 | 0.27 |
| Net Income Per Share | -0.07 | -0.09 | 0.03 | 0.08 | 0.04 |
| Tax Burden | 1.18 | 1.06 | 1.31 | 1.63 | 0.73 |
| Interest Burden | 1.66 | 1.23 | 0.47 | 0.76 | 0.72 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.29 | 0.32 | 0.24 | 0.28 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.01 | 0.04 | 0.03 |
| Income Quality | -0.65 | -0.15 | 1.01 | 0.54 | 2.34 |
Currency in USD
